Store brand Vioxx alternatives
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products is capitalizing on Merck's recent withdrawal of Vioxx (rofecoxib) through in-store signage for its store-brand pain relievers. Leiner is working with retailers to place shelf-talkers with phrases such as "proven safe and effective to treat minor arthritis pain" next to products like naproxen sodium. The effort follows a recent spate of ads touting OTC use over COX-2 inhibitors (1"The Tan Sheet" Oct. 11, 2004, p. 3)...
You may also be interested in...
Wyeth, McNeil Strike Swiftly With Ads After Vioxx Recall
Wyeth Consumer Health and McNeil are capitalizing on concerns generated by Merck's recall of its prescription pain reliever Vioxx with ads for Advil (ibuprofen) and Tylenol (acetaminophen)
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.